Final-Program-ATS-2023-AP.vp

64

SUNDAY • MAY 21

P723 Insights on the Management and Outcomes of Patients With Progressive Fibrosing Interstitial Lung Disease in Clinical Practice: INSIGHTS-ILD Registry/ J. Behr, Munchen, Germany P724 Spectrum and Profile of Patients With Interstitial Lung Diseases Presenting at a Tertiary Care Centre in North India/ I. Shekh, New Delhi, India P725 The Spectrum of Presentations Associated With Myositis-Related Interstitial Lung Disease (ILD) - a Single Centre Series/ C.M. Gill, Dublin, Ireland P726 Interstitial Lung Disease in Anti-synthetase Syndrome: A Single Center Experience/ M. Khasawneh, Gainesville, FL P727 Anti-Nuclear Matrix Protein-2 (NXP-2) Antibodies in Interstitial Lung Disease: A Rare Manifestation of a Rare Disease/ B. Flashner, Boston, MA P728 Multifaceted Analysis of Interstitial Pneumonias With Autoimmue Features: A Prospective Multicenter Cohort Study/ N. Enomoto, Hamamatsu, Japan P729 Clinical and Radiographic Characterization of Non-specific Interstitial Pneumonia on High-resolution CT Chest Imaging/ V. Marcoux, Saskatoon, Canada P730 Description of Chest CT Patterns in Patients With Connective Tissue Diseases Related Interstitial Lung Diseases (ILD) in an ILD Clinic in Canada: A Quasi Population-based Study/ S. Gunn, Kingston, Canada P731 Prevalence, Computed Tomography Patterns, and Risk Factors for Development of Connective Tissue Disease Associated Interstitial Lung Disease: A Systematic Review and Meta-analysis/ G.M. Joy, Vancouver, Canada P732 Comparative Study of the Clinical Features and Prognosis Between Idiopathic Pulmonary Fibrosis and Unclassifiable Interstitial Pneumonia/ K. Koda, Hamamatsu, Japan P733 Intrafamilial Correlation and Variability in the Clinical Evolution of Pulmonary Fibrosis/ T. Goos, Leuven, Belgium P734 Prevalence and Mortality of Idiopathic Pulmonary Fibrosis in Brazil/ R. Rufino, Rio de Janeiro, Brazil P735 Hospitalisation Patterns in Interstitial Lung Disease - Data From the Exciting-ILD Registry/ M. Kreuter, Heidelberg, Germany P736 Risk Assessment for Acute Exacerbations of Interstitial Lung Disease/ R. Dinparastisaleh, Jacksonville, FL P737 Histological Predictors of Progression and Mortality in Fibrotic Interstitial Lung Diseases/ V. El Mir Arida, Sao Paulo, Brazil P738 Risk Factors for Progressive Pulmonary Fibrosis in Primary Sjögren Interstitial Lung Disease/ S.J. Auteri, Buenos Aires, Argentina

P709 An Unusual Case Of Pneumonia And Hemoptysis/ A. Khodadadi, St. Louis, MO P710 EGPA - Takes My Breath Away/ R. Patel, Norwalk, CT P711 A Rare Presentation Of Atypical Anti-Glomerular Basement Membrane Disease/ C.J. Fernandez, Buffalo, NY P712 Another Case of the Sniffles: Chronic Sinusitis and Recurrent Otitis Media in Granulomatosis With Polyangiitis/ E.M.P. Almazan, Lexington, KY P713 Diffuse Alveolar Hemorrhage Associated With Anti-synthetase Syndrome and COVID-19/ P. Shah, West Reading, PA P714 ANCA Negative Granulomatosis With Polyangiitis With Associated Progressive and Extensive Emphysema/ C.J. Merino Gualan, Norwalk, CT P715 All That Glitters Is Not Gold - A Curious Case of Granulomatosis With Polyangiitis With Predominant Pulmonary Involvement/ P. Shekar, Hartford, CT P716 Rapid Onset of Diffuse Alveolar Hemorrhage in Newly Diagnosed Granulomatosis With Polyangiitis: A Case Report/ S. Shah, Abington, PA P717 A Bloody Affair - IgA Vasculitis Presenting As Diffuse Alveolar Hemorrhage Post COVID-19/ J. Alunilkummannil, Cleveland, OH P718 Diffuse Alveolar Hemorrhage - A Commonly Encountered But Often Missed Diagnosis/ A. Makadia, Corpus Christi, TX

CLINICAL • TRANSLATIONAL THEMATIC POSTER SESSION

A38

ADVANCING OUR UNDERSTANDING AND TREATMENT OF ILD

9:00 a.m. - 4:15 p.m.

Walter E. Washington Convention Center Area G, Hall C (Lower Level)

Viewing : Posters will be on display for entire session

11:30-1:15

Discussion: 11:30-12:15 authors will be present for individual discussion

12:15-1:15 authors will be present for discussionwith assigned facilitators.

P720 Association Between Statin Use and the Risk for Idiopathic Pulmonary Fibrosis and Its Prognosis/ J. Park, Seoul, Korea, Republic of P721 Cigarette Smoking and Risk of Interstitial Lung Disease Diagnosis: A Systematic Review and Meta-Analysis/ C. Lee, Chicago, IL P722 Non-Tobacco Exposures in Combined Pulmonary Fibrosis and Emphysema Across ILDs: A Case-Control Analysis/ C. Lee, Chicago, IL

ATS 2023 • Washington, DC